Endovascular Treatment of Abdominal Aorto-Caval Fistula With Occluder Devices: Case Report and Systematic Literature Review DOI
Claudio Bianchini Massoni,

Laura Pauletti,

Andrea Andreone

et al.

Journal of Endovascular Therapy, Journal Year: 2025, Volume and Issue: unknown

Published: March 21, 2025

Aortocaval fistula (ACF) is a life-threatening condition secondary to abdominal aortic aneurysms (AAA) rupture or previous trauma/intervention. The treatment of ACF by an occluder device deployment rare but increasingly common approach. We report case ruptured AAA treated with after endograft deployment. A 66-year-old male was in emergent setting for deploying aorto-bi-iliac endograft. At 3-month computed tomography angiography (CTA), the persistence aorto-caval communication and increased sac reperfusion (type II endoleak) from lumbar inferior mesenteric artery were detected. Under local anesthesia through percutaneous left brachial arterial access right femoral venous access, 7-mm Amplatzer Septal Occluder deployed “left” atrial end aneurysmal “right” vena cava. adjunctive embolization performed. post-procedural CTA 6-month contrast-enhanced ultrasound confirmed disappearance endoleak exclusion ACF. systematic review literature according Preferred Reporting Items Systematic Reviews Meta-Analysis (PRISMA) statement conducted regarding use devices treat (PROSPERO; CRD42024512167). Including current case, 10 patients (male 100%; age range 24–74 years) publications found. trauma described 6 4 patients, respectively. primary procedure 6/10 cases intervention 4/10 cases. Different types (vascular 4/10, septal 3/10, duct 2/10, ventricular 1/10) used. Technical success 100%, no intraoperative complications. Postoperative complications occurred 2/10 plug migration iliac deep vein thrombosis). Three out required reintervention within 30 days persistent patency (1 endovascular aneurysm repair, 1 re-embolization coils, patient underwent iliolumbar embolization). In 8/10 (length follow-up: 1–80 months), residual arterio-venous communication. 3 AAA, shrinkage 3/3 type case. Although scarce number are available literature, into feasible. For traumatic ACF, could be proposed as treatment, while, mandatory. Clinical Impact occlusion off-label technique reported literature. technical mainly depends device. This should first approach post-traumatic without aneurysms; endograft, placement considered

Language: Английский

Endovascular Treatment of Abdominal Aorto-Caval Fistula With Occluder Devices: Case Report and Systematic Literature Review DOI
Claudio Bianchini Massoni,

Laura Pauletti,

Andrea Andreone

et al.

Journal of Endovascular Therapy, Journal Year: 2025, Volume and Issue: unknown

Published: March 21, 2025

Aortocaval fistula (ACF) is a life-threatening condition secondary to abdominal aortic aneurysms (AAA) rupture or previous trauma/intervention. The treatment of ACF by an occluder device deployment rare but increasingly common approach. We report case ruptured AAA treated with after endograft deployment. A 66-year-old male was in emergent setting for deploying aorto-bi-iliac endograft. At 3-month computed tomography angiography (CTA), the persistence aorto-caval communication and increased sac reperfusion (type II endoleak) from lumbar inferior mesenteric artery were detected. Under local anesthesia through percutaneous left brachial arterial access right femoral venous access, 7-mm Amplatzer Septal Occluder deployed “left” atrial end aneurysmal “right” vena cava. adjunctive embolization performed. post-procedural CTA 6-month contrast-enhanced ultrasound confirmed disappearance endoleak exclusion ACF. systematic review literature according Preferred Reporting Items Systematic Reviews Meta-Analysis (PRISMA) statement conducted regarding use devices treat (PROSPERO; CRD42024512167). Including current case, 10 patients (male 100%; age range 24–74 years) publications found. trauma described 6 4 patients, respectively. primary procedure 6/10 cases intervention 4/10 cases. Different types (vascular 4/10, septal 3/10, duct 2/10, ventricular 1/10) used. Technical success 100%, no intraoperative complications. Postoperative complications occurred 2/10 plug migration iliac deep vein thrombosis). Three out required reintervention within 30 days persistent patency (1 endovascular aneurysm repair, 1 re-embolization coils, patient underwent iliolumbar embolization). In 8/10 (length follow-up: 1–80 months), residual arterio-venous communication. 3 AAA, shrinkage 3/3 type case. Although scarce number are available literature, into feasible. For traumatic ACF, could be proposed as treatment, while, mandatory. Clinical Impact occlusion off-label technique reported literature. technical mainly depends device. This should first approach post-traumatic without aneurysms; endograft, placement considered

Language: Английский

Citations

0